Showing results (131-140 of 225) with videos related to

Sort By:
Pageof 23
Critical Reviews in Oncology/Hematology|March 15, 2023
Matching BRCA and prostate cancer in a public health system: Report of the Italian Society for Uro-Oncology (SIUrO) consensus projectAlberto Lapini, Orazio Caffo, Giario Natale Conti, et al.
Anticancer Research|August 1, 2018
Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian ExperienceAndrea Sbrana, Elisa Biasco, Federico Paolieri, et al.
Targeted Oncology|November 29, 2024
Defining the Position of [177Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical TrialsChiara Ciccarese, Matteo Bauckneht, Luca Zagaria, et al.
Future Oncology (London, England)|June 4, 2016
Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancerGaetano Aurilio, Maria Teresa Sandri, Giancarlo Pruneri, et al.
Targeted Oncology|September 1, 2018
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Claudia Mosillo, et al.
American Journal of Clinical Oncology|September 12, 2018
Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access ProgramMichele Prisciandaro, Raffaele Ratta, Francesco Massari, et al.
Urologia Internationalis|July 6, 2018
Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical ProstatectomyAntonio Benito Porcaro, Alessandro Tafuri, Marco Sebben, et al.
Immunotherapy|June 4, 2019
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysisAntonio Rossi, Vincenzo Di Noia, Anastasios Gkountakos, et al.
Pathology, Research and Practice|September 8, 2018
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistanceCaterina Vicentini, Cinzia Cantù, Davide Antonello, et al.
Anticancer Research|February 27, 2022
Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?Chiara Ciccarese, Roberto Iacovelli, Sebastiano Buti, et al.
Pageof 23